These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33523004)

  • 1. Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.
    Yu F; Vock DM; Zhang L; Salisbury D; Nelson NW; Chow LS; Smith G; Barclay TR; Dysken M; Wyman JF
    J Alzheimers Dis; 2021; 80(1):233-244. PubMed ID: 33523004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial).
    Yu F; Bronas UG; Konety S; Nelson NW; Dysken M; Jack C; Wyman JF; Vock D; Smith G
    Trials; 2014 Oct; 15():394. PubMed ID: 25304364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular biomarkers to predict response to exercise in Alzheimer's disease: the study protocol.
    Li D; Thomas R; Tsai MY; Li L; Vock DM; Greimel S; Yu F
    BMJ Open; 2016 Dec; 6(12):e011054. PubMed ID: 28039287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial.
    Yu F; Lin FV; Salisbury DL; Shah KN; Chow L; Vock D; Nelson NW; Porsteinsson AP; Jack C
    Trials; 2018 Dec; 19(1):700. PubMed ID: 30577848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-individual differences in the responses to aerobic exercise in Alzheimer's disease: Findings from the FIT-AD trial.
    Yu F; Salisbury D; Mathiason MA
    J Sport Health Sci; 2021 Jan; 10(1):65-72. PubMed ID: 32505710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 6-month aerobic exercise on Alzheimer's symptoms.
    Yu F; Thomas W; Nelson NW; Bronas UG; Dysken M; Wyman JF
    J Appl Gerontol; 2015 Jun; 34(4):484-500. PubMed ID: 24652914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Effects of Aerobic Exercise in Alzheimer's Disease: Imaging Findings From the Pilot FIT-AD Trial.
    Yu F; Mathiason MA; Han S; Gunter JL; Jones D; Botha H; Jack C
    Front Aging Neurosci; 2021; 13():703691. PubMed ID: 34690736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial.
    Morris JK; Vidoni ED; Johnson DK; Van Sciver A; Mahnken JD; Honea RA; Wilkins HM; Brooks WM; Billinger SA; Swerdlow RH; Burns JM
    PLoS One; 2017; 12(2):e0170547. PubMed ID: 28187125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
    Lamb SE; Mistry D; Alleyne S; Atherton N; Brown D; Copsey B; Dosanjh S; Finnegan S; Fordham B; Griffiths F; Hennings S; Khan I; Khan K; Lall R; Lyle S; Nichols V; Petrou S; Zeh P; Sheehan B
    Health Technol Assess; 2018 May; 22(28):1-202. PubMed ID: 29848412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of an interactive cycling training on cognitive functioning in older adults with mild dementia: study protocol for a randomized controlled trial.
    Karssemeijer EG; Bossers WJ; Aaronson JA; Kessels RP; Olde Rikkert MG
    BMC Geriatr; 2017 Mar; 17(1):73. PubMed ID: 28327083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).
    Li D; Mielke MM; Bell WR; Reilly C; Zhang L; Lin FV; Yu F
    Trials; 2020 Jan; 21(1):19. PubMed ID: 31907024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive activity for the treatment of older adults with mild Alzheimer's disease (AD)--PACE AD: study protocol for a randomised controlled trial.
    Vidovich MR; Shaw J; Flicker L; Almeida OP
    Trials; 2011 Feb; 12():47. PubMed ID: 21329501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
    Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
    Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic exercise and vascular cognitive impairment: A randomized controlled trial.
    Liu-Ambrose T; Best JR; Davis JC; Eng JJ; Lee PE; Jacova C; Boyd LA; Brasher PM; Munkacsy M; Cheung W; Hsiung GR
    Neurology; 2016 Nov; 87(20):2082-2090. PubMed ID: 27760869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Exercise on Cognitive Function in Older People with Dementia: A Randomized Controlled Trial.
    Toots A; Littbrand H; Boström G; Hörnsten C; Holmberg H; Lundin-Olsson L; Lindelöf N; Nordström P; Gustafson Y; Rosendahl E
    J Alzheimers Dis; 2017; 60(1):323-332. PubMed ID: 28800328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease.
    Irizarry MC; Webb DJ; Bains C; Barrett SJ; Lai RY; Laroche JP; Hosford D; Maher-Edwards G; Weil JG
    J Alzheimers Dis; 2008 Jul; 14(3):301-11. PubMed ID: 18599956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial.
    Kamphuis PJ; Verhey FR; Olde Rikkert MG; Twisk JW; Swinkels SH; Scheltens P
    J Nutr Health Aging; 2011 Aug; 15(8):720-4. PubMed ID: 21968871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.